We provided regulatory counsel to Cardinal Health Specialty Solutions in its acquisition of RainTree Oncology Services, a large independent group purchasing organization for oncology practices and clinics. Our representation included, conducting a preliminary diligence report to identify the target’s compliance issues; evaluating the effects of the acquisition on business operations (i.e. funds flow analysis); and leading a regulatory review to understand the effects of the acquisition on operation matters (i.e. physician compensation arrangements).
Details of the transaction were outlined in the article, "Another Significant Specialty Deal: Cardinal Health Buys Raintree Oncology," published on DrugChannels.net.
Cardinal Health Specialty Solutions provides clinical, reimbursement, technology and distribution services that help health care professionals, payers and pharmaceutical and biotech companies improve the quality and cost-effectiveness of caring for patients who are managing complex diseases.